help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on August 9, 2005
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-0373
A more recent version of this article appeared on November 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
90/11/5985    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gumieniak, O.
Right arrow Articles by Williams, G. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gumieniak, O.
Right arrow Articles by Williams, G. H.

Submitted on February 22, 2005
Accepted on July 29, 2005

Aggregation of High-Normal TSH in Hypertensive Families

Olga Gumieniak, Shelley Hurwitz, Todd S. Perlstein, U. Chioma Ngumezi, Paul N. Hopkins, Xavier Jeunemaitre, and Gordon H. Williams*

Endocrinology, Diabetes and Hypertension Division, (O.G., S.H., U.C.N., G.H.W.), and the Division of Cardiology (T.S.P.), Department of Medicine, Brigham and Women's Hospital, Harvard Medical School; and Cardiovascular Genetics, Cardiology Division, University of Utah(P.N.H.), and Department of Genetics and Clinical Investigation Centre (X.J.), APHP 9201, Hopital Europeen Georges Pompidou, Paris, France

* To whom correspondence should be addressed. E-mail: gwilliams{at}partners.org.

Background: Studies suggest that there are genetic variants that influence both blood pressure regulation and serum TSH levels. We investigated if high-normal TSH values aggregate in hypertensive families. The influence of hypertension family history on serum TSH levels in healthy normotensive individuals was also examined.

Methods: All subjects were euthyroid (TSH 0.5-5.0 mIU/L). 333 hypertensives, including 229 members of multiple sibling families had blood samples for serum TSH determination drawn in the morning after overnight bedrest. High-normal TSH was defined as values > 2.0 mIU/L and ≤ 5.0 mIU/L. 31 healthy normotensives provided information about their family history of hypertension by telephone.

Results: The concordance for high-normal TSH values among hypertensive multiple sibling families was greater than expected by chance (P = 0.009). There were nearly twice as many families concordant for high-normal TSH status as expected (13.2% vs. 7.0%), while the observed proportion concordant for normal-TSH status was similar to that expected (58.3% vs. 54.1%). Family membership explained a significant proportion of variance in TSH status (P = 0.038). Healthy normotensives with family history of hypertension had significantly higher TSH values (2.2 ± 1.2 mIU/L) compared with those with negative family history of hypertension (TSH 1.3 ± 0.7 mIU/L) independent of other characteristics (P = 0.025).

Conclusions: There is familial aggregation of high-normal TSH values in hypertensive families and hypertension family history influences serum TSH levels in healthy individuals. These findings are consistent with the existence of genetic variants affecting both blood pressure regulation and serum TSH levels.


Key words: Hypertension • genetics • TSH • siblings




This article has been cited by other articles:


Home page
HypertensionHome page
A. L. Maia, S.-J. Hwang, D. Levy, M. G. Larson, P. R. Larsen, and C. S. Fox
Lack of Association Between the Type 2 Deiodinase A/G Polymorphism and Hypertensive Traits: The Framingham Heart Study
Hypertension, April 1, 2008; 51(4): e22 - e23.
[Full Text] [PDF]


Home page
Endocr. Rev.Home page
B. Biondi and D. S. Cooper
The Clinical Significance of Subclinical Thyroid Dysfunction
Endocr. Rev., February 1, 2008; 29(1): 76 - 131.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. O. Asvold, T. Bjoro, T. I. L. Nilsen, and L. J. Vatten
Association between Blood Pressure and Serum Thyroid-Stimulating Hormone Concentration within the Reference Range: A Population-Based Study
J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 841 - 845.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
O. Gumieniak, T. S. Perlstein, J. S. Williams, P. N. Hopkins, N. J. Brown, B. A. Raby, and G. H. Williams
Ala92 Type 2 Deiodinase Allele Increases Risk for the Development of Hypertension
Hypertension, March 1, 2007; 49(3): 461 - 466.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J.-M. Fernandez-Real, A. Lopez-Bermejo, A. Castro, R. Casamitjana, and W. Ricart
Thyroid Function Is Intrinsically Linked to Insulin Sensitivity and Endothelium-Dependent Vasodilation in Healthy Euthyroid Subjects
J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3337 - 3343.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society